NCT03298451 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- All treatment-emergent adverse events (TEAEs) were collected up to the final analysis DCO (27Aug2021, to a maximum of approximately 46 months).
- Other-event reporting threshold
- 5%
TEAE was defined as any AE that started after dosing or prior to dosing and worsens following treatment exposure. AE was observed up until 90 days following discontinuation of the last dose of study drug, or until the initiation of the first subsequent therapy following discontinuation of treatment. All-cause mortality was reported for all randomized participants. Adverse events were reported for participants who received at least 1 dose of study drug regardless of the randomized assignment.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Durva 1500 mg | 115 / 388 | 299 / 388 | 280 / 389 |
| Treme 300 mg x1 Dose + Durva 1500 mg | 157 / 388 | 334 / 388 | 262 / 393 |
| Treme 75 mg x4 Doses + Durva 1500 mg | 52 / 152 | 133 / 152 | 123 / 153 |
| Sora 400 mg | 111 / 374 | 333 / 374 | 293 / 389 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Immune system disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 152
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Haemophagocytic lymphohistiocytosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Device related infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Enterocolitis infectious
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 388
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Gastroenteritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Hepatitis c
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Lower respiratory tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Meningitis listeria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Necrotising fasciitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 388
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 152
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Peritonitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Pneumocystis jirovecii pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 388
- num Events
- 3
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 388
- num Events
- 7
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 152
- num Events
- 6
- group Id
- EG003
- num Affected
- 8
- num At Risk
- 374
- num Events
- 8
- term
- Pneumonia
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 42
- num At Risk
- 388
- num Events
- 49
- group Id
- EG001
- num Affected
- 35
- num At Risk
- 388
- num Events
- 45
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 152
- num Events
- 9
- group Id
- EG003
- num Affected
- 20
- num At Risk
- 374
- num Events
- 26
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 388
- num Events
- 11
- group Id
- EG001
- num Affected
- 28
- num At Risk
- 388
- num Events
- 38
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 152
- num Events
- 6
- group Id
- EG003
- num Affected
- 10
- num At Risk
- 374
- num Events
- 17
- term
- Amylase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 54
- num At Risk
- 388
- num Events
- 63
- group Id
- EG001
- num Affected
- 46
- num At Risk
- 388
- num Events
- 53
- group Id
- EG002
- num Affected
- 16
- num At Risk
- 152
- num Events
- 17
- group Id
- EG003
- num Affected
- 24
- num At Risk
- 374
- num Events
- 33
- term
- Aspartate aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 388
- num Events
- 30
- group Id
- EG001
- num Affected
- 19
- num At Risk
- 388
- num Events
- 23
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 152
- num Events
- 5
- group Id
- EG003
- num Affected
- 29
- num At Risk
- 374
- num Events
- 32
- term
- Blood bilirubin increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 12
- num At Risk
- 388
- num Events
- 12
- group Id
- EG001
- num Affected
- 18
- num At Risk
- 388
- num Events
- 18
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 152
- num Events
- 7
- group Id
- EG003
- num Affected
- 19
- num At Risk
- 374
- num Events
- 24
- term
- Gamma-glutamyltransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 388
- num Events
- 27
- group Id
- EG001
- num Affected
- 32
- num At Risk
- 388
- num Events
- 38
- group Id
- EG002
- num Affected
- 8
- num At Risk
- 152
- num Events
- 10
- group Id
- EG003
- num Affected
- 15
- num At Risk
- 374
- num Events
- 17
- term
- Lipase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 53
- num At Risk
- 388
- num Events
- 58
- group Id
- EG001
- num Affected
- 65
- num At Risk
- 388
- num Events
- 69
- group Id
- EG002
- num Affected
- 24
- num At Risk
- 152
- num Events
- 24
- group Id
- EG003
- num Affected
- 67
- num At Risk
- 374
- num Events
- 72
- term
- Decreased appetite
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 32
- num At Risk
- 388
- num Events
- 35
- group Id
- EG001
- num Affected
- 28
- num At Risk
- 388
- num Events
- 35
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 152
- num Events
- 11
- group Id
- EG003
- num Affected
- 13
- num At Risk
- 374
- num Events
- 13
- term
- Back pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 28
- num At Risk
- 388
- num Events
- 29
- group Id
- EG001
- num Affected
- 32
- num At Risk
- 388
- num Events
- 39
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 152
- num Events
- 15
- group Id
- EG003
- num Affected
- 31
- num At Risk
- 374
- num Events
- 32
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 388
- num Events
- 4
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 388
- num Events
- 11
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 152
- num Events
- 12
- group Id
- EG003
- num Affected
- 12
- num At Risk
- 374
- num Events
- 14
- term
- Pain in extremity
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 21
- num At Risk
- 388
- num Events
- 21
- group Id
- EG001
- num Affected
- 40
- num At Risk
- 388
- num Events
- 44
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 152
- num Events
- 10
- group Id
- EG003
- num Affected
- 16
- num At Risk
- 374
- num Events
- 16
- term
- Insomnia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 388
- num Events
- 9
- group Id
- EG001
- num Affected
- 30
- num At Risk
- 388
- num Events
- 31
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 152
- num Events
- 10
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 374
- num Events
- 2
- term
- Hyperthyroidism
Complete source fields
- description
- TEAE was defined as any AE that started after dosing or prior to dosing and worsens following treatment exposure. AE was observed up until 90 days following discontinuation of the last dose of study drug, or until the initiation of the first subsequent therapy following discontinuation of treatment. All-cause mortality was reported for all randomized participants. Adverse events were reported for participants who received at least 1 dose of study drug regardless of the randomized assignment.
- event Groups
- deaths Num Affected
- 280
- deaths Num At Risk
- 389
- description
- Durvalumab 1500 mg every 4 weeks (Q4W)
- id
- EG000
- other Num Affected
- 299
- other Num At Risk
- 388
- serious Num Affected
- 115
- serious Num At Risk
- 388
- title
- Durva 1500 mg
- deaths Num Affected
- 262
- deaths Num At Risk
- 393
- description
- Tremelimumab 300 mg × 1 dose + durvalumab 1500 mg Q4W
- id
- EG001
- other Num Affected
- 334
- other Num At Risk
- 388
- serious Num Affected
- 157
- serious Num At Risk
- 388
- title
- Treme 300 mg x1 Dose + Durva 1500 mg
- deaths Num Affected
- 123
- deaths Num At Risk
- 153
- description
- Tremelimumab 75 mg Q4W × 4 doses + durvalumab 1500 mg Q4W
- id
- EG002
- other Num Affected
- 133
- other Num At Risk
- 152
- serious Num Affected
- 52
- serious Num At Risk
- 152
- title
- Treme 75 mg x4 Doses + Durva 1500 mg
- deaths Num Affected
- 293
- deaths Num At Risk
- 389
- description
- Sorafenib 400 mg twice daily (BID)
- id
- EG003
- other Num Affected
- 333
- other Num At Risk
- 374
- serious Num Affected
- 111
- serious Num At Risk
- 374
- title
- Sora 400 mg
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 42
- num At Risk
- 388
- num Events
- 49
- group Id
- EG001
- num Affected
- 35
- num At Risk
- 388
- num Events
- 45
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 152
- num Events
- 9
- group Id
- EG003
- num Affected
- 20
- num At Risk
- 374
- num Events
- 26
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 388
- num Events
- 11
- group Id
- EG001
- num Affected
- 28
- num At Risk
- 388
- num Events
- 38
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 152
- num Events
- 6
- group Id
- EG003
- num Affected
- 10
- num At Risk
- 374
- num Events
- 17
- term
- Amylase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 54
- num At Risk
- 388
- num Events
- 63
- group Id
- EG001
- num Affected
- 46
- num At Risk
- 388
- num Events
- 53
- group Id
- EG002
- num Affected
- 16
- num At Risk
- 152
- num Events
- 17
- group Id
- EG003
- num Affected
- 24
- num At Risk
- 374
- num Events
- 33
- term
- Aspartate aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 388
- num Events
- 30
- group Id
- EG001
- num Affected
- 19
- num At Risk
- 388
- num Events
- 23
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 152
- num Events
- 5
- group Id
- EG003
- num Affected
- 29
- num At Risk
- 374
- num Events
- 32
- term
- Blood bilirubin increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 12
- num At Risk
- 388
- num Events
- 12
- group Id
- EG001
- num Affected
- 18
- num At Risk
- 388
- num Events
- 18
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 152
- num Events
- 7
- group Id
- EG003
- num Affected
- 19
- num At Risk
- 374
- num Events
- 24
- term
- Gamma-glutamyltransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 388
- num Events
- 27
- group Id
- EG001
- num Affected
- 32
- num At Risk
- 388
- num Events
- 38
- group Id
- EG002
- num Affected
- 8
- num At Risk
- 152
- num Events
- 10
- group Id
- EG003
- num Affected
- 15
- num At Risk
- 374
- num Events
- 17
- term
- Lipase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 53
- num At Risk
- 388
- num Events
- 58
- group Id
- EG001
- num Affected
- 65
- num At Risk
- 388
- num Events
- 69
- group Id
- EG002
- num Affected
- 24
- num At Risk
- 152
- num Events
- 24
- group Id
- EG003
- num Affected
- 67
- num At Risk
- 374
- num Events
- 72
- term
- Decreased appetite
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 32
- num At Risk
- 388
- num Events
- 35
- group Id
- EG001
- num Affected
- 28
- num At Risk
- 388
- num Events
- 35
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 152
- num Events
- 11
- group Id
- EG003
- num Affected
- 13
- num At Risk
- 374
- num Events
- 13
- term
- Back pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 28
- num At Risk
- 388
- num Events
- 29
- group Id
- EG001
- num Affected
- 32
- num At Risk
- 388
- num Events
- 39
- group Id
- EG002
- num Affected
- 13
- num At Risk
- 152
- num Events
- 15
- group Id
- EG003
- num Affected
- 31
- num At Risk
- 374
- num Events
- 32
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 388
- num Events
- 4
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 388
- num Events
- 11
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 152
- num Events
- 12
- group Id
- EG003
- num Affected
- 12
- num At Risk
- 374
- num Events
- 14
- term
- Pain in extremity
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 21
- num At Risk
- 388
- num Events
- 21
- group Id
- EG001
- num Affected
- 40
- num At Risk
- 388
- num Events
- 44
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 152
- num Events
- 10
- group Id
- EG003
- num Affected
- 16
- num At Risk
- 374
- num Events
- 16
- term
- Insomnia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 9
- num At Risk
- 388
- num Events
- 9
- group Id
- EG001
- num Affected
- 30
- num At Risk
- 388
- num Events
- 31
- group Id
- EG002
- num Affected
- 9
- num At Risk
- 152
- num Events
- 10
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 374
- num Events
- 2
- term
- Hyperthyroidism
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Immune system disorders
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 152
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Haemophagocytic lymphohistiocytosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Device related infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Enterocolitis infectious
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 388
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Gastroenteritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Hepatitis c
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Lower respiratory tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Meningitis listeria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Necrotising fasciitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 388
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 152
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 374
- num Events
- 1
- term
- Peritonitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 388
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 388
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 152
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 374
- num Events
- 0
- term
- Pneumocystis jirovecii pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 23.1
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 388
- num Events
- 3
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 388
- num Events
- 7
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 152
- num Events
- 6
- group Id
- EG003
- num Affected
- 8
- num At Risk
- 374
- num Events
- 8
- term
- Pneumonia
- time Frame
- All treatment-emergent adverse events (TEAEs) were collected up to the final analysis DCO (27Aug2021, to a maximum of approximately 46 months).
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle